Clinical Trials Directory

Trials / Completed

CompletedNCT05122637

Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Stroke Patients

Feasibility Study of RapidPulseTM Aspiration System as Frontline Approach for Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
RapidPulse, Inc · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Feasibility Study to evaluate the initial safety and performance of the RapidPulseTM Aspiration System in the treatment of patients with Acute Ischemic Stroke (AIS) due to Large Vessel Occlusion (LVO).

Detailed description

The purpose of this study is to evaluate the initial safety and performance of the RapidPulse Inc. RapidPulseTM Aspiration System as frontline approach for use in the treatment of patients with Acute Ischemic Stroke (AIS) due to Large Vessel Occlusion (LVO). This is a prospective, multi-center, open label study comparing the safety and performance of the RapidPulseTM Aspiration System with non-randomized retrospective controls who otherwise meet the same study inclusion/exclusion criteria. The study will enroll a maximum of 100 participants in the Treatment Arm and a maximum of 200 participants in the Control Arm at in up to 10 centers in Europe and/or Latin America. Subjects data will be collected through hospitalization with a 3 months post-procedure study visit.

Conditions

Interventions

TypeNameDescription
DEVICERapidPulseTM Aspiration SystemThe RapidPulseTM Aspiration System with Medtronic React 71 aspiration catheter and a commercially available pump.
DEVICEStandard of Care Aspiration Thrombectomy SystemCommercially available aspiration catheter with commercially available aspiration pump

Timeline

Start date
2022-01-31
Primary completion
2022-09-23
Completion
2022-12-20
First posted
2021-11-17
Last updated
2023-03-02

Locations

5 sites across 5 countries: Brazil, Denmark, Latvia, Spain, Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05122637. Inclusion in this directory is not an endorsement.